Literature DB >> 7561919

Spastic tetraplegia as an initial manifestation of familial Alzheimer's disease.

N Sodeyama1, M Shimada, T Uchihara, K Yanagisawa, H Fujigasaki, K Yamaguchi, M Matsushita, M Yamada.   

Abstract

Two sisters with familial Alzheimer's disease developed spastic gait disturbance as an initial manifestation. Their gait disturbance progressed gradually, followed by dementia a few years later. Post-mortem examination of one of the patients disclosed degeneration of the thalamus and corticospinal tract in addition to numerous senile plaques and neurofibrillary tangles in the neocortex, both of which were confirmed by immunohistochemistry. This is the first report in which clinicopathological evaluation is sufficient to establish a new variant of Alzheimer's disease presenting initially as spastic tetraplegia.

Entities:  

Mesh:

Year:  1995        PMID: 7561919      PMCID: PMC486076          DOI: 10.1136/jnnp.59.4.395

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  23 in total

1.  Alzheimer's disease. Presentation of a case with pathologic and enzymatic-histochemical observatins.

Authors:  R L FRIEDE; K R MAGEE
Journal:  Neurology       Date:  1962-03       Impact factor: 9.910

2.  [Case of encephalopathy with plaque-like bodies, neurofibrillary change, angiopathy and amyotrophic lateral sclerosis-like lesions].

Authors:  T Matsuoka; K Miyoshi; K Saka; T Kawagoe; T Nishikiori
Journal:  Shinkei Kenkyu No Shimpo       Date:  1967

3.  Lack of the carboxyl terminal sequence of tau in ghost tangles of Alzheimer's disease.

Authors:  R Endoh; M Ogawara; T Iwatsubo; I Nakano; H Mori
Journal:  Brain Res       Date:  1993-01-22       Impact factor: 3.252

4.  Mutational analysis of the amyloid precursor protein gene in Japanese familial Alzheimer's disease kindreds.

Authors:  H Fujigasaki; S Naruse; K Kaneko; H Hirasawa; S Tsuji; T Miyatake
Journal:  Hum Genet       Date:  1994-04       Impact factor: 4.132

5.  A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease.

Authors:  J T O'Brien; S Eagger; G M Syed; B J Sahakian; R Levy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

6.  Mass spectrometry of purified amyloid beta protein in Alzheimer's disease.

Authors:  H Mori; K Takio; M Ogawara; D J Selkoe
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

7.  A new inherited prion disease (PrP-P105L mutation) showing spastic paraparesis.

Authors:  T Kitamoto; N Amano; Y Terao; Y Nakazato; T Isshiki; T Mizutani; J Tateishi
Journal:  Ann Neurol       Date:  1993-12       Impact factor: 10.422

8.  Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene.

Authors:  R Medori; H J Tritschler; A LeBlanc; F Villare; V Manetto; H Y Chen; R Xue; S Leal; P Montagna; P Cortelli
Journal:  N Engl J Med       Date:  1992-02-13       Impact factor: 91.245

9.  Fatal familial insomnia: clinical and pathologic study of five new cases.

Authors:  V Manetto; R Medori; P Cortelli; P Montagna; P Tinuper; A Baruzzi; G Rancurel; J J Hauw; J J Vanderhaeghen; P Mailleux
Journal:  Neurology       Date:  1992-02       Impact factor: 9.910

10.  System degeneration of the thalamus. A clinico-neuropathological study.

Authors:  A Hori; K Ikeda; K Kosaka; S Shinohara; R Iizuka
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.